More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-05-18-10-28-58-943-6a0ae9ea7b28cf1ee1c1b2eb.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-05-12-09-43-44-572-6a02f6508f76c0fb5883f3ff.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-05-12-10-43-37-159-6a030459203bc3ae3a46a4ea.jpg)